within Pharmacolibrary.Drugs.ATC.J;

model J01DB04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 5.5e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.009300000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0056,
    k12             = 7.5,
    k21             = 7.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DB04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cefazolin is a first-generation cephalosporin antibiotic used primarily for the treatment of a variety of bacterial infections, including those of the skin, bone, joint, respiratory tract, urinary tract, and for surgical prophylaxis. It is an approved drug widely used in clinical practice due to its efficacy and safety profile.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following a single intravenous bolus dose.</p><h4>References</h4><ol><li><p>Balevic, SJ, et al., &amp; Cohen-Wolkowiez, M (2019). Cefazolin pharmacokinetics in premature infants. <i>Journal of perinatology : official journal of the California Perinatal Association</i> 39(9) 1213–1218. DOI:<a href=&quot;https://doi.org/10.1038/s41372-019-0368-z&quot;>10.1038/s41372-019-0368-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30944398/&quot;>https://pubmed.ncbi.nlm.nih.gov/30944398</a></p></li><li><p>Alli, A, et al., &amp; Roberts, JA (2023). Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery. <i>PloS one</i> 18(9) e0291425–None. DOI:<a href=&quot;https://doi.org/10.1371/journal.pone.0291425&quot;>10.1371/journal.pone.0291425</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37729151/&quot;>https://pubmed.ncbi.nlm.nih.gov/37729151</a></p></li><li><p>White, RR, et al., &amp; Song, J (2008). Pharmacokinetics of topical and intravenous cefazolin in patients with clean surgical wounds. <i>Plastic and reconstructive surgery</i> 122(6) 1773–1779. DOI:<a href=&quot;https://doi.org/10.1097/PRS.0b013e31818d5899&quot;>10.1097/PRS.0b013e31818d5899</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19050530/&quot;>https://pubmed.ncbi.nlm.nih.gov/19050530</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DB04;
